Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6480730 | 0.79 | L3MBTL1 (0.41) | KDM4EL3MBTL1 | |
| SCHEMBL27876260 | 0.77 | KDM4E (0.39) | KDM4EL3MBTL1 | |
| SCHEMBL28204394 | 0.76 | TSHR (0.39) | KDM4EL3MBTL1 | |
| SCHEMBL7622688 | 0.75 | KDM4E (0.38) | KDM4EL3MBTL1 | |
| SCHEMBL7522493 | 0.75 | HDAC3 (0.50) | KDM4EL3MBTL1 | |
| SCHEMBL6039510 | 0.74 | — | — | |
| SCHEMBL10518755 | 0.74 | — | — | |
| SCHEMBL27656889 | 0.73 | KDM4E (0.37) | KDM4EL3MBTL1 | |
| SCHEMBL2774457 | 0.70 | — | — | |
| SCHEMBL6227802 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | GIVAUDAN SA (CH) | 2008-12-11 | — | — | US | disclosed |
| EP-1838278-A1 | 2-C-SUBSTITUTED PROPANE-1,3-DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | Givaudan SA (CH) | 2007-10-03 | — | — | EP | disclosed |
| WO-2006076821-A1 | 2 -C-SUBSTITUTED PROPANE-1, 3 -DICARBONYL COMPOUNDS AND THEIR USE IN NEUTRALISING MALODOUR | GIVAUDAN SA (CH) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305066-A1 | 2-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour | TYR, MAL2, ACMSD | KDM4E 1182/4885L3MBTL1 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.